Corrigendum to "Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca/CaMKII pathway" [J. Pharm. Anal. 14 (2024) 435-438].

J Pharm Anal

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

Published: June 2024

[This corrects the article DOI: 10.1016/j.jpha.2023.09.016.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284492	PMC
http://dx.doi.org/10.1016/j.jpha.2024.101025	DOI Listing

Publication Analysis

corrigendum "active

"active components

components dengzhan

dengzhan shengmai

shengmai ameliorate

ameliorate cognitive

cognitive impairment

impairment facilitating

facilitating hippocampal

hippocampal long-term

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!